VisMederi Research

Recent papers from VisMederi Research

1. Exposure of dogs to influenza A and B virusesOne Health · 2026
2. Investigating the relationship between relative accuracy and linearity acceptance criteria in bioassay validation for clinical studiesBioanalysis · 2026
3. Case Report: Primed dendritic cell immunotherapy for multiple solid tumorsFrontiers in Immunology · 2026
4. Association Between Immunosuppressive Cell Populations and Immune Response to Influenza Vaccination in Younger and Older AdultsVaccines · 2026
5. Impact of ABO Blood System on Immunogenicity and Vaccine Efficacy of COVID‐19 Booster Vaccination—A Population‐Based Study of 3066 IndividualsInfluenza and Other Respiratory Viruses · 2026
6. Qualification of a high-throughput luminescence-based Serum Bactericidal Activity assay to assess the functionality of human sera against five Shigella serotypesVaccine · 2026
7. Therapeutic inhibition of telomeric DNA damage response rescues hematopoietic dysfunction driven by telomere shortening and agingNature Aging · 2026
8. A colorimetric readout based on the PrestoBlue® dye as an objective method for measuring neutralizing antibodies against influenza virus in human serum samplesBiochemistry and Biophysics Reports · 2026
9. Development and validation of a pseudotyped virus neutralization assay for quantification of anti-Lassa virus neutralizing antibodiesFrontiers in Immunology · 2026
10. Development and characterization of pseudotype-based microneutralization assay to assess functionality of anti-rabies protein G antibodiesF1000Research · 2026
11. Development and Qualification of a Pseudotyped Virus‐Based Microneutralisation Assay for Influenza D VirusInfluenza and Other Respiratory Viruses · 2026
12. Development of an intranasal, universal influenza vaccine in an EU-funded public-private partnership: the FLUniversal consortiumFrontiers · 2025
13. Seroprevalence of Influenza D Virus in Cattle Workers: An Occupational Health PerspectiveJournal of Medical Virology · 2026
14. Circulation of influenza D virus in Ukraine: A multi-species serological studyActa Tropica · 2026
15. Extended Heterosubtypic Neutralization and Preclinical Model In Vivo Protection from Clade 2.3.4.4b H5 Influenza Virus Infection by Broadly Neutralizing AntibodiesVaccines · 2026
16. Influenza vaccination post-COVID-19 expands vaccine-specific effector CD4 T-cells and Tregs under positive influence of host trained innate immunitynpj Vaccines · 2025
17. High-dose influenza vaccine: enhanced protection for the elderlyExpert Review of Vaccines · 2025
18. Influenza D Virus Circulation Among Bovines, Swine, Equines, and Wild Boars in Italy: A Sero-Epidemiological StudyPathogens · 2025
19. Dose-sparing effects of novel adjuvants and aluminum hydroxide on two different vaccines in a neonatal mouse modelFrontiers in Immunology · 2025
20. SARS-CoV-2, influenza, HRSV and other respiratory pathogens during the post-COVID-19 era: epidemic circulation in Italy in the 2023/2024 seasonJournal of Infection and Public Health · 2025